SCHEMBL4181732

SCHEMBL4181732

Cc1ccccc1C#CC(=O)NCCc1ccc(Cl)c(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAAT3 P53816 1/20 0.49
PLAAT5 Q96KN8 1/20 0.49
PLAAT2 Q9NWW9 1/20 0.49
PLAAT4 Q9UL19 1/20 0.49
PYGL P06737 2/20 0.48
LIPG Q9Y5X9 3/20 0.44
GRIN1 Q05586 1/20 0.43
GRIN2B Q13224 1/20 0.43
BCL2A1 Q16548 1/20 0.43
TRPV1 Q8NER1 4/20 0.43
LIPC P11150 2/20 0.41
FFAR1 O14842 1/20 0.41
CHRM2 P08172 1/20 0.41
S1PR1 P21453 1/20 0.41
FPR1 P21462 1/20 0.41
FPR3 P25089 1/20 0.41
GPR183 P32249 1/20 0.41
APLNR P35414 1/20 0.41
FFAR4 Q5NUL3 1/20 0.41
GPR65 Q8IYL9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4166991 0.91 PYGL (0.46) PLAAT3PLAAT5PLAAT2PLAAT4PYGL
SCHEMBL4174123 0.86 ALDH1A1 (0.53) PLAAT3PLAAT5PLAAT2PLAAT4TAAR1
SCHEMBL4186377 0.86 PLAAT3 (0.49) PLAAT3PLAAT5PLAAT2PLAAT4PYGL
SCHEMBL4181935 0.84 PLAAT3 (0.49) PLAAT3PLAAT5PLAAT2PLAAT4FFAR1
SCHEMBL4181751 0.83 PYGL (0.59) PLAAT3PLAAT5PLAAT2PLAAT4PYGL
SCHEMBL4166987 0.81 PLAAT3 (0.47) PLAAT3PLAAT5PLAAT2PLAAT4FFAR1
SCHEMBL4173472 0.81 PYGL (0.60) PLAAT3PLAAT5PLAAT2PLAAT4PYGL
SCHEMBL4168072 0.81 PYGL (0.50) PLAAT3PLAAT5PLAAT2PLAAT4PYGL
SCHEMBL4175049 0.80 PYGL (0.56) PLAAT3PLAAT5PLAAT2PLAAT4PYGL
SCHEMBL4178958 0.79 PYGL (0.58) PLAAT3PLAAT5PLAAT2PLAAT4PYGL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090182020-A1 SUBSTITUTED BIS(HETERO)AROMATIC N--ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS GRUNENTHAL GMBH (DE) 2009-07-16 US claimed
EP-1968935-A1 SUBSTITUTED BIS(HETERO)AROMATIC N-ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS Grünenthal GmbH (DE) 2008-09-17 EP claimed
WO-2007079958-A1 SUBSTITUTED BIS(HETERO)AROMATIC N-ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS Grünenthal GmbH (DE) 2007-07-19 WO claimed
US-20090182020-A1 SUBSTITUTED BIS(HETERO)AROMATIC N--ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS GRUNENTHAL GMBH (DE) 2009-07-16 US disclosed
EP-1968935-A1 SUBSTITUTED BIS(HETERO)AROMATIC N-ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS Grünenthal GmbH (DE) 2008-09-17 EP disclosed
WO-2007079958-A1 SUBSTITUTED BIS(HETERO)AROMATIC N-ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS Grünenthal GmbH (DE) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090182020-A1 SUBSTITUTED BIS(HETERO)AROMATIC N--ETHYLPROPIOLAMIDES AND USE THEREOF FOR PRODUCTION OF MEDICAMENTS FHIT, CYP3A43, DNPEP PLAAT3 2664/4885PLAAT5 2707/4885PLAAT2 2933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.